A Vaccine (STEMVAC) for Improving Survival in Patients With Triple-Negative Breast Cancer and Moderate or Extensive Residual Cancer Burden
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Triple-Negative Breast Carcinoma
Interventions
- BIOLOGICAL: CD105/Yb-1/SOX2/CDH3/MDM2-polyepitope Plasmid DNA Vaccine
- DRUG: Recombinant Granulocyte-Macrophage Colony-Stimulating Factor
- PROCEDURE: Biospecimen Collection
Sponsor
University of Washington
Collaborators